A study published in JMIR Pediatrics and Parenting evaluated current tele-concussion practices. With the Covid-19 pandemic challenging the United States’ healthcare system, many clinics have transitioned to telehealth practices to protect patients by eliminating inessential visits.

The Canadian company PreveCeutical Medical has developed a sustained-release CBD formulation of their Sol-gel pain-relief technology. These easy-to-use treatments release cannabinoids into the central nervous system through nasal mucosal tissue.